Join Our Mailing List
 
Contact Us     Privacy Policy     Terms of Use                                                                                  © Copyright Pharma CI Conference & Exhibition.  All Rights Reserved.
PHARMA ADVISORY BOARD:              
  Monika Giese
Head of Global Competitive Intelligence
Novartis Pharma AG

Monika Giese  is currently the Head of Global Competitive
Intelligence at Novartis Pharma at their strategic HQ in
Switzerland.  

Before working at Novartis, Monika worked for GSK,  Solvay, IMS
International and F.Hoffmann – La Roche. Her experience  ranges
from information management via market research and business
analytics to a variety of functions in competitive intelligence.

Monika  is a biologist by training, and also holds certified degrees
in pharmacology, Information Science, Market Research and
Competitive Intelligence.  She’s currently also a member of the
Strategic Insights Leadership Forum.

_______________________________________
  Craig McHenry
Senior Director, Competitor Insights
Wyeth

Craig joined Wyeth (formerly American Home Products
Corporation) in 1991 and advanced his understanding of the
pharmaceutical industry while working in several business
functions.  He started in Global Business Development and
Licensing before moving to manage the Secondary Research
Analysis function.  He has also worked in Marketing Research
where he spent two years directing oncology and hematology
market research in the Wyeth BioPharma business unit.  Since
early in his career at Wyeth, Craig has been involved with
competitive intelligence.  In 1993, Craig played a key role in
forming the first Business and Competitive Intelligence function,
which has evolved over the years into the current group that he
directs called Competitor Insights.  One of a handful of groups
focused on specific analysis techniques, this group provides CI
consulting, expertise, and oversight to brand teams, new product
groups, and Senior Management.  Before Wyeth, Craig spent five
years at Unisys and holds a M.A. in Computer Science Ed.  He has
been a member of SCIP since 1993 and is a graduate from the
Gilead-Herring Academy of Competitive Intelligence.

____________________________________________________
  Dr. Daniel R. Pascheles
Vice President, Global Competitive Intelligence
Merck & Co., Inc.

Dr. Daniel R. Pascheles is Vice President, Global Competitive
Intelligence, and is based in Whitehouse Station NJ, at the Global
HQ of Merck & Co., Inc.

His responsibilities include providing intelligence regarding
business, research and development activities of competitors, as
well as participating in, and contribution to the strategy
development process, the target identification for licensing and
M&A activities.

Pascheles joined Merck & Co., Inc. early 2005 from Aventis Inc.
where he was Vice President and head of Corporate Competitive
Intelligence. He has worked for Aventis and its predecessor
company (Hoechst Marion Roussel, Marion Merrell Dow) for 14
years in various positions and locations.

Pascheles studied Pharmacy at the Swiss Federal Institute of
Technology in Zurich, Switzerland. He received his Ph.D. in
Pharmaceutical Technology from the same university.  He has
done additional study at the University of Kansas in Lawrence,
Kansas.

Pascheles is Past-President and current Board member of the
Pharmaceutical Business Intelligence & Research Group (PBIRG).
He is also member of the Society of Competitive Intelligence
Professionals (SCIP) and the Licensing Executive Society (LES).

_______________________________________
  Dawn Renear
Vice President, Competitive & Technical Information
Genzyme Corp.

Dawn Renear is Vice President of Competitive & Technical
Information at Genzyme Corporation in Cambridge, MA. She
oversees two intelligence functions: Technical Intelligence and
Competitive & Market Intelligence. These groups are responsible
for providing intelligence to all areas of the corporation, and are
fully integrated into both business and science teams.

Dawn is responsible for integrating intelligence activities into
business processes and growing corporation recognition of
effective intelligence processes. Also under her responsibility is
the Global Library group.

Prior to Genzyme, Dawn was Manager of Information Services at
Integrated Genetics, Inc. and Analyst at the Center for the
Analysis of Health Practices, Harvard School of Public Health.
Dawn has over 25 years of experience in the biopharma industry.
She holds a B.A. in Art History from the University of
Massachusetts at Amherst and M.S. in Information Science from
Simmons College.

_______________________________________
  David Stefanoni
Head of Business Intelligence
Sanofi-Aventis

David Stefanoni is Head of Business Intelligence at sanofi-
aventis.  He is responsible for managing the BI process for sanofi-
aventis in the US and directly supports key corporate initiatives.  
David has been in the medical / pharmaceutical industry for 17
years and has experience in the areas of wound care, infection
control, antihypetensives, infectious diseases, pain management,
oncology, rheumatoid arthritis, Crohn’s disease, & medical
dermatology.

Prior to joining sanofi-aventis in October, 2004, David worked with
Centocor, a biotechnology division of Johnson & Johnson.  David
has a BSBA in Business Administration from Truman State
University and a MSHSA from Southwest Baptist University.  

____________________________________________________
  Sue Ward
Director, Competitive Intelligence
Pfizer Global Research & Development

Sue Ward is currently Director of Competitive Intelligence within
Pfizer Global Research & Development.  Before working at Pfizer,
Sue worked in the UK as Associate Director of Competitive
Analysis for SmithKline Beecham (SB) (now GlaxoSmithKline).  
Other positions held within SB’s R&D division included Manager
of a Clinical Information group and Manager of the Product
Literature Information Service.  Sue holds a BSc (Hons) in Biology
from University College, London and an MSc in Information
Science from The City University, London.  Sue is a member of
the Society of Competitive Intelligence Professionals (SCIP).
  Sarah Audet
Director of Technology Planning
Medtronic

Sarah received her Bachelor of Science degree from the State
University of New York at Upstate Medical Center in the area of
Medical Technology, Master’s of Science Degree in Electrical
Engineering from Boston University, and her PhD in Electrical
Engineering from the Technical University of Delft, the
Netherlands. Sarah also received a Master’s in Business
Administration in 2008.

Sarah has worked in the area of sensor and emerging technology
design, development, and manufacture since 1990 at several
companies including AT&T Bell Labs, Princeton Gamma-Tech,
Motorola, and Medtronic. Sarah is currently the Director of
Technology Planning at Medtronic, where she has worked since
1997.

In addition to her direct responsibilities, Sarah is involved with
mentoring local high school students, mentoring women in
science fields, and advising k – 12 educational Science,
Technology, Engineering, and Math (STEM) programs to educate
students in the area of science.

____________________________________________________
  Beth Autin
Manager, Library Services
Gen-Probe


Beth Autin has over ten years of experience in the
Pharmaceutical, Medical Diagnostic/Biotech, Chemical and
Legal industries.  She has been Manager of Library Services and
Information Management at Gen-Probe Incorporated since
March, 2005.  In this broad role, she has established the Corporate
Information Center, providing centralized information services to
colleagues in R&D, Marketing, Strategic Planning, Business
Development and Operations.  In addition to providing traditional
library services, business and competitive intelligence, she led the
team to redesign the corporate intranet, playing an integral role in
the layout, design and search functionality.

Prior to Gen-Probe, she worked at Pfizer Global Research and
Development and Ligand Pharmaceuticals, both in the San
Diego area.  She is a member of the Special Libraries
Association, Pharma & Health Technology and Business &
Finance Divisions.  She holds a B.A. in Art History and Master of
Library and Information Science from Louisiana State University.

_______________________________________
    Jeffrey Beeny
Corporate Development – Business Intelligence
Thermo Fisher Scientific

Jeffrey Beeny is the Senior Manager of Business Intelligence at
Thermo Fisher Scientific.  

From May 2006 through November 2006, he was a key member of
the Fisher Scientific anti-trust team working on the company’s
$10.6 billion merger with Thermo Electron. In support of the
company’s regulatory filings, Mr. Beeny managed the business
intelligence process, an essential component of approval from the
Federal Trade Commission (FTC) and European Commission (EC).
He joined Fisher Scientific in January 2006 with the responsibility
for strategic, market and competitive analysis in support of
corporate initiatives and strategic decision-making.

Prior to joining Fisher Scientific, Mr. Beeny was the Principal
Market Analyst, Competitive Intelligence at EMC Corporation. At
EMC, Mr. Beeny was responsible for competitive and market
analysis for the company’s corporate strategy focused on
information lifecycle management. Prior to EMC, he was the
Manager of Competitive Intelligence at Genuity, where he led
competitive and strategic analysis initiatives for senior
management. In the mid- to late-1990s, Mr. Beeny was a Risk
Financing Analyst at Liberty Mutual and a Scientist for The
Gillette Company - Duracell. He holds a B.S. General Science in
Chemistry from Purdue University and earned an M.B.A. in
Finance and Strategy from Boston College. Mr. Beeny has been a
member of the Society of Competitive Intelligence Professionals
since 2000.

____________________________________________________
    Robert Franc
Director of Competitive Intelligence
Lifescan

Robert Franc has over 26 years of Competitive Intelligence
Experience; 12 years working for the US Government and 14 years
in the pharmaceutical industry. He has developed CI programs in
the US, Europe, Asia & the Middle East. During his 14 years in the
pharmaceutical industry, he has supported R&D and commercial
organizations, both in the US & Europe.

_______________________________________
  Kim Szymanowski
Competitive Intelligence Manager
Ethicon, a Johnson & Johnson Company

Kim Szymanowski has worked at Ethicon, a Johnson & Johnson
medical device company for the past 24 years.   She has worked
in most functional areas throughout the organization including:
        12+ years in Suture, Needle, Packaging and Sterilization
Manufacturing
        5+ years in New Product Development
        3+ years in Resource & Portfolio Management
        1+ years in Strategic Planning
        3 years in Competitive Intelligence (within Marketing)

Kim has helped build the Competitive Intelligence function and
foundation over the past 3 years at Ethicon.  This has included
developing internal systems to help improve access and
disseminate intelligence to the organization.  Several of these
systems have been highlighted as a Best Practice within J&J and
are being leveraged across the sectors.   With the medical device
business being quite different from the pharmaceutical industry,
data access and availability is extremely difficult to obtain.  This
has resulted in creative approaches to build competitive pipelines
using a number of different sources available from public
domains.  The past three years have been an incredibly exciting
time in the medical device Competitive Intelligence business  - it’
s been a tremendous learning curve for Kim.

Kim has a Bachelor’s of Science degree in Industrial Engineering
and has been a member of SCIP for the past 2 years.

_______________________________________
  Richard Traxler
Senior Manager of Technology Planning
Boston Scientific Corporation

Richard’s resume includes Research & Development and
Manufacturing Engineering management positions in Fortune 500
companies in the automotive, (United Technologies Corporation),
electronics, (Seagate Technology Corporation), and medical
device industries (Boston Scientific Corporation).   In his current
role as Senior Manager of Technology Planning at Boston
Scientific's Cardiovascular Division, Richard has developed &
implemented a highly successful form of Technology
Roadmapping that is a major element of Boston Scientific’s new
product development portfolio planning.  This roadmapping
practice has significantly helped focus Boston Scientific’s
Research and Development investments.  Richard has BS & MS
degrees in Engineering and holds seven medical device patents.  
He resides in Minneapolis with his wife and Labradoodle pup.

____________________________________________________
    David Van Mook
Manager, CI
Roche Diagnostics

David Van Mook is currently Manager of Competitive Intelligence
at Roche Diagnostics.

Prior to accepting his current position at Roche, Mr. Van Mook
was an independent competitive intelligence consultant for major
corporations such as Microsoft. He was also Manager of
Competitive Intelligence at LexisNexis, with primary responsibility
for supporting global strategic planning. In this capacity, he
managed numerous studies in South America, Asia and Europe
focusing on due diligence for potential acquisitions and
partnerships.

Mr. Van Mook received an MBA from Kellogg Graduate School of
Management at Northwestern University and graduated with high
honors from Princeton University.
     
DEVICE/DIAGNOSTIC ADVISORY BOARD:
BOARD OF ADVISORS:                                                                         
SEPTEMBER 21-22
HILTON PARSIPPANY HOTEL
NEW JERSEY